These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27324884)

  • 1. Factors influencing immunologic response to hepatitis B vaccine in adults.
    Yang S; Tian G; Cui Y; Ding C; Deng M; Yu C; Xu K; Ren J; Yao J; Li Y; Cao Q; Chen P; Xie T; Wang C; Wang B; Mao C; Ruan B; Jiang T; Li L
    Sci Rep; 2016 Jun; 6():27251. PubMed ID: 27324884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease.
    Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1053-62. PubMed ID: 15569107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
    Wong J; Payne M; Hollenberg S
    J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suitable hepatitis B vaccine for adult immunization in China: a systematic review and meta-analysis.
    Wu Z; Bao H; Yao J; Chen Y; Lu S; Li J; Jiang ZG; Ren JJ; Xu KJ; Ruan B; Yang SG; Xie TS; Hu Y
    Hum Vaccin Immunother; 2019; 15(1):220-227. PubMed ID: 30089437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?
    Ni JD; Xiong YZ; Wang XJ; Xiu LC
    Int J STD AIDS; 2013 Feb; 24(2):117-22. PubMed ID: 23467291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to hepatitis B vaccination in drug using populations: a systematic review and meta-regression analysis.
    Kamath GR; Shah DP; Hwang LY
    Vaccine; 2014 Apr; 32(20):2265-74. PubMed ID: 24631093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis.
    Van Der Meeren O; Crasta P; Cheuvart B; De Ridder M
    Hum Vaccin Immunother; 2015; 11(7):1726-9. PubMed ID: 25996260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience.
    Van Den Ende C; Marano C; Van Ahee A; Bunge EM; De Moerlooze L
    Expert Rev Vaccines; 2017 Aug; 16(8):811-832. PubMed ID: 28573913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current views on the persistence of immunity following hepatitis B vaccination.
    Madaliński K; Kołakowska A; Godzik P
    Przegl Epidemiol; 2015; 69(1):47-51, 147-50. PubMed ID: 25862447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-dose hepatitis B vaccine for adults (Heplisav-B).
    Med Lett Drugs Ther; 2018 Jan; 60(1539):17-18. PubMed ID: 29364196
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
    Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
    Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults.
    Jackson S; Lentino J; Kopp J; Murray L; Ellison W; Rhee M; Shockey G; Akella L; Erby K; Heyward WL; Janssen RS;
    Vaccine; 2018 Jan; 36(5):668-674. PubMed ID: 29289383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States.
    Trantham L; Kurosky SK; Zhang D; Johnson KD
    Vaccine; 2018 Aug; 36(35):5333-5339. PubMed ID: 29909136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Viral Hepat; 2011 Oct; 18(10):730-7. PubMed ID: 20819147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccination among the Nicobarese tribe: Need to document the impact.
    Murhekar M
    Indian J Med Res; 2015 May; 141(5):662. PubMed ID: 26139786
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: A systematic review and meta-analysis.
    Jiang HY; Wang SY; Deng M; Li YC; Ling ZX; Shao L; Ruan B
    Vaccine; 2017 May; 35(20):2633-2641. PubMed ID: 28404358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
    Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon.
    Tatsilong HO; Noubiap JJ; Nansseu JR; Aminde LN; Bigna JJ; Ndze VN; Moyou RS
    BMC Public Health; 2016 Aug; 15():706. PubMed ID: 27487845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.